Literature DB >> 3087881

Lymphokine-activated-killer-mediated lysis of cells infected with typhus group rickettsiae can be inhibited by OKT3 monoclonal antibody.

M Carl, G A Dasch.   

Abstract

We examined the ability of monoclonal antibodies directed against lymphocyte surface antigens to block the lysis of typhus group rickettsia-infected cells by lymphokine-activated killer effectors. Lysis was significantly inhibited by OKT3 monoclonal antibody but not by OKT4 or OKT8 monoclonal antibody.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3087881      PMCID： PMC260101          DOI： 10.1128/iai.53.1.226-228.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  13 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  The T3 complex on human T lymphocytes involves four structurally distinct glycoproteins.

Authors:  J Borst; S Alexander; J Elder; C Terhorst
Journal:  J Biol Chem       Date:  1983-04-25       Impact factor: 5.157

3.  Molecular interactions in human T cell-mediated cytotoxicity to EBV II. Monoclonal antibody OKT3 inhibits a post-killer-target recognition/adhesion step.

Authors:  C D Tsoukas; D A Carson; S Fong; J H Vaughan
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

4.  Surface structures involved in target recognition by human cytotoxic T lymphocytes.

Authors:  S C Meuer; R E Hussey; J C Hodgdon; T Hercend; S F Schlossman; E L Reinherz
Journal:  Science       Date:  1982-10-29       Impact factor: 47.728

5.  Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

Authors:  M Rosenstein; I Yron; Y Kaufmann; S A Rosenberg
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

6.  T cell subpopulations required for the human cytotoxic T lymphocyte response to influenza virus: evidence for T cell help.

Authors:  W E Biddison; S O Sharrow; G M Shearer
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

7.  Use of a sensitive microplate enzyme-linked immunosorbent assay in a retrospective serological analysis of a laboratory population at risk to infection with typhus group rickettsiae.

Authors:  S Halle; G A Dasch
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

8.  Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.

Authors:  E A Grimm; K M Ramsey; A Mazumder; D J Wilson; J Y Djeu; S A Rosenberg
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

9.  Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.

Authors:  E A Grimm; R J Robb; J A Roth; L M Neckers; L B Lachman; D J Wilson; S A Rosenberg
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

10.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.